EP 1009433 A4 20050316 - THERAPEUTIC COMPOSITION AND METHOD OF TREATMENT
Title (en)
THERAPEUTIC COMPOSITION AND METHOD OF TREATMENT
Title (de)
THERAPEUTISCHE ZUSAMMENSETZUNG UND VERFAHREN ZUR BEHANDLUNG
Title (fr)
COMPOSITION THERAPEUTIQUE ET PROCEDE DE TRAITEMENT
Publication
Application
Priority
- US 9812401 W 19980616
- US 87751197 A 19970617
Abstract (en)
[origin: WO9857661A1] The present invention is methods and compositions including a photoactivated antibody that is capable of generating or increasing an immune response.
IPC 1-7
IPC 8 full level
A61K 41/00 (2006.01); A61K 39/395 (2006.01); A61P 37/02 (2006.01); A61P 37/04 (2006.01); A61P 43/00 (2006.01); C07K 16/30 (2006.01); A61K 39/00 (2006.01)
CPC (source: EP US)
A61P 37/02 (2018.01 - EP); A61P 37/04 (2018.01 - EP); A61P 43/00 (2018.01 - EP); C07K 16/3069 (2013.01 - EP); A61K 39/00 (2013.01 - EP US); A61K 2039/505 (2013.01 - EP)
Citation (search report)
- [X] WO 9318792 A1 19930930 - BIOMIRA INC [CA]
- [A] DATABASE MEDLINE [online] US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US; February 1996 (1996-02-01), STALTERI M A ET AL: "Technetium-99m labelling of the anti-tumour antibody PR1A3 by photoactivation.", XP002313121, Database accession no. NLM8925853 & STALTERI M A ET AL: "Technetium-99m labelling of the anti-tumour antibody PR1A3 by photoactivation.", February 1996, EUROPEAN JOURNAL OF NUCLEAR MEDICINE. FEB 1996, VOL. 23, NR. 2, PAGE(S) 178 - 187, ISSN: 0340-6997
- See also references of WO 9857661A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9857661 A1 19981223; AU 732505 B2 20010426; AU 8143998 A 19990104; CA 2292912 A1 19981223; EP 1009433 A1 20000621; EP 1009433 A4 20050316; JP 2002504154 A 20020205
DOCDB simple family (application)
US 9812401 W 19980616; AU 8143998 A 19980616; CA 2292912 A 19980616; EP 98931277 A 19980616; JP 50463299 A 19980616